4 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 4 Not applicable, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 1, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Smokeless Tobacco: new trials by email Literature Review of Smokeless Tobacco trials Research Report on Smokeless Tobacco
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects Copenhagen group, Snus group - Smokeless Tobacco | Not applicable | Recruiting | Roswell Park Cancer Institute | 50 | 2026-05-11 | 2026-05-22 |
| Effect of Passive Smoking on Functional Capacity, Cognition and Academic Performance in Primary School Children Smoke Exposure, Smokeless Tobacco | Not yet recruiting | Egyptian Chinese University | 90 | 2024-12-15 | 2024-12-18 | |
| Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure Herbal Snuff (Smokeless Tobacco) - Smokeless Tobacco | Phase 1 | Active not recruiting | Masonic Cancer Center, University of Minnesota | 55 | 2021-10-19 | 2025-11-26 |
| Treating Smokeless Tobacco Use in Rural Veterans Tailored behavioral intervention, Behavioral activation for elevated depressive symptoms, Post-cessation weight gain management - Smokeless Tobacco, Nicotine Dependence | Not applicable | Unknown | Mark Vander Weg | 123 | 2016-12-01 | 2019-07-24 |
| Human Laboratory Study of Smokeless Tobacco Products Nicotine Lozenge, Stonewall Dissolvable Tobacco Pieces, Camel Snus Frost - Smokeless Tobacco | Not applicable | Withdrawn | University of Minnesota | 2010-03-01 | 2014-12-10 | |
| Telephone Counseling for Snuff Users Phone counseling and written materials - Smokeless Tobacco, Tobacco Use Cessation | Not applicable | Completed | HealthPartners Institute | 400 | 2004-11-01 | 2023-08-24 |
| In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus Buccal administration of nicotine - Smoking Cessation, Smokeless Tobacco | Phase 1 | Completed | Contract Research Organization el AB | 32 | 2004-05-01 | 2011-06-09 |
| In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus Buccal Administration of nicotine - Smoking Cessation, Smokeless Tobacco | Phase 1 | Completed | Contract Research Organization el AB | 32 | 2004-05-01 | 2010-11-29 |
| Bupropion SR for Treating Smokeless Tobacco Use Bupropion SR - Smokeless Tobacco | Phase 3 | Completed | Mayo Clinic | 225 | 2003-08-01 | 2011-03-14 |
Tobacco Use (9) · Harm Reduction (2) · Smoking Cessation (2) · Tobacco Use Cessation (2) · Tobacco Use Disorder (1)
Behavior (9) · Health Behavior (4) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Substance-Related Disorders (1)
Tobacco, Smokeless (3) · Tobacco Use Cessation Devices (2) · Bupropion (1) · Contraindications (1) · Ethanol (1) · Health Records, Personal (1) · Nicotine Chewing Gum (1) · Varenicline (1)
Contract Research Organization el AB (2) · Egyptian Chinese University (1) · HealthPartners Institute (1) · Mark Vander Weg (1) · Masonic Cancer Center, University of Minnesota (1) · Mayo Clinic (1) · Roswell Park Cancer Institute (1) · University of Minnesota (1)
United States (6) · Sweden (2)
Erik Lunell, MD, PhD (2) · Irina Stepanov, PhD (1) · Lowell C. Dale, M.D. (1) · Marc Mooney, Ph.D. (1) · Mark W. Vander Weg, PhD (1) · Nancy E Sherwood, PhD (1)
R21CA289541 (1)